Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M219,919Revenue $M45,087Net Margin (%)22.0Z-Score4.4
Enterprise Value $M236,134EPS $2.9Operating Margin %31.6F-Score6
P/E(ttm))22.4Cash Flow Per Share $0Pre-tax Margin (%)27.9Higher ROA y-yY
Price/Book17.310-y EBITDA Growth Rate %23.0Quick Ratio0Cash flow > EarningsY
Price/Sales4.95-y EBITDA Growth Rate %1.3Current Ratio0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-9.3ROA % (ttm)15.2Higher Current Ratio y-yN
Dividend Yield %2.9Insider Buy (3m)0ROE % (ttm)77.2Less Shares Outstanding y-yN
Payout Ratio %60.0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with RHHBY

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 80. The trades of Premium Gurus are not included unless they are in your Personalized List

TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RHHBYKen Fisher 2013-03-31 Add0.12%$50.5 - $58.6
($55.48)
$ 63.1314%Add 634.57%897,861
RHHBYTweedy Browne 2012-09-30 Reduce-0.03%$41.9 - $48.14
($44.81)
$ 63.1341%Reduce -24.31%62,164
RHHBYVanguard Health Care Fund 2012-06-30 Add2.96%$38.94 - $46.28
($42.32)
$ 63.1349%Add 543.36%4,273,977
RHHBYKen Fisher 2012-06-30 Reduce-0.01%$38.94 - $46.28
($42.32)
$ 63.1349%Reduce -24.26%154,713
RHHBYKen Fisher 2012-03-31 Reduce-1.27%$43.1 - $44.33
($40.08)
$ 63.1358%Reduce -98.02%204,276
RHHBYTweedy Browne 2012-03-31 Reduce-0.04%$43.1 - $44.33
($40.08)
$ 63.1358%Reduce -22.19%82,130
RHHBYKen Fisher 2009-03-31 Add1.01%$26.73 - $37.06
($31.9)
$ 63.1398%Add 96.11%12,225,393
RHHBYVanguard Health Care Fund 2009-03-31 Reduce-0.2%$26.73 - $37.06
($31.9)
$ 63.1398%Reduce -52.1%429,320
RHHBYVanguard Health Care Fund 2008-12-31 Add2.01%$62.65 - $77
($71.1)
$ 63.13-11%Add 95.76%5,113,297
RHHBYPRIMECAP Management 2008-12-31 Sold Out -1.2%$62.65 - $77
($71.1)
$ 63.13-11%Sold Out0
RHHBYKen Fisher 2008-12-31 Reduce-1.15%$16.11 - $39.83
($35.03)
$ 63.1380%Reduce -56.79%6,233,841
RHHBYPRIMECAP Management 2008-09-30 Buy 1.2%$40.1 - $45.78
($43)
$ 63.1347%New holding, 4306500 sh.4,306,500
RHHBYKen Fisher 2008-06-30 Add1.14%$39.9 - $47.38
($42.8)
$ 63.1348%Add 223.59%7,046,449
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RHHBY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
RHHBY Ken Fisher 2013-03-31897,861 0.14+634.57%
RHHBY Tweedy Browne 2013-03-3160,274 0.09
Premium Most recent portfolio changes are included for Premium Members only!


RHHBY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RHHBY:

Quarterly/Annual Reports about RHHBY:

    News about RHHBY:

    Articles On GuruFocus.com
    How Faithful Are You? Mar 31 2013 
    Value Idea Update: Roche (RHHBY) Mar 21 2013 
    Tweedy Browne Q3 Letter Nov 01 2012 
    52-Week High Companies: PRGO, NOC, RHHBY, NXY, PFE Oct 15 2012 
    Edwards Owens Buys Green Mountain Coffee and Allscripts, Adds to Others Aug 02 2012 
    Best Health Care Investor Edward Owens Buys One New Health Care Stock in First Quarter Apr 30 2012 
    Roche Is Paying Down Its Debt Apr 27 2012 
    Investing Mistakes and What Not to Do (End 2009-Mid 2010) Jan 27 2012 
    Tweedy, Browne Q4 Letter - All Funds Up, Named 2011 Int'l-Stock Fund Manager of the Year Jan 26 2012 
    Illumina's "Poison Pill" Against Roche's Hostile Takeover Might Drive the Share Price Much Higher Jan 26 2012 

    More From Our Partners
    Good News for Roche's Tarceva - Analyst Blog May 16 2013 - ZACKS

    Add Notes, Comments or Ask Questions

    Comments

    No comment yet
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
    Free 7-day Trial